Epidemiological observations have demons trated that hepatitis A virus (HAV) occurs throughout the world. In our country, is responsible for 50% of hepatitis cases diagnosed at the National Reference Center for Viral Hepatitis, Oswaldo Cruz Foundation, Rio de Janeiro.
Following the discovery of hepatitis A virus (HAV)6, a number of methods such as immuneadherence haemagglutinationl 5 and complement fixa tion1^ have been described for the detection of anti-HAV antibodies and for the separation of early (IgM) and late (IgG) antibodies12. More recently, third generation tests such as radioimmunoassay® 20; ancj enzyme linked immunosorbent assay4 have been developed and shown to be suitable for routine serodiagnosis.
The propagation of HAV in various cells lines5 7 1011 14 18 , has provided an alternative to the use of feces collected in the preicteric phase from human hepatitis A cases or from experimentally infected primates as sources of antigen for serological assays.
This paper describes the development and stan dardization of two competitive enzyme immunoassays (EIA) for HAV antibodies and compares the results with those obtained with a commercial EIA.
MATERIAL AND METHODS

Sera
Standardization of both competitive tests was performed using convalescent serum from a patient with serologically confirmed hepatitis A as positive control and an antibody-negative serum as negative control. The reproducibility of both procedures was evaluated using a reference panel with twenty-two sera previously tested for anti-HAV antibodies by a com mercial EIA kit (Hepanostika anti-HAV, Organon Teknika, Holland). The panel had twelve sera serolo gically diagnosed as hepatitis A and ten sera from healthy blood donors without anti-HAV antibodies.
Antigen Preparation
Two strains of HAV virus wére grown in fetal rhesus monkey kidney cells (FRhK-4), HAS-15 (Cen ter for Disease Control) and HM-175 (Walter Reed Army Institute). Fivemlofeachvirus(O.D. at450nm = 0.235 in EIA HAV-TEST -in house production) was adsorbed at 37°C onto confluent cell sheets of 150cm2 tissue culture flasks (Falcon, Becton Dickin son Co) for two hours. After adsorption, cultures were maintened at 37°C with 50ml of Williama's medium (Sigma Chemical Co) supplemented with 2% L glutamin 0,83 ml (Sigma), lOmM MEM Non Essential Amino Acids 0,83 ml(Sigma), 1M HEPES 1.66 ML (Sigma), 7.5% sodium bicarbonate 1.66 ml, 50 mg/ml gentamicin 0.25 ml and 2% fetal calf serum (Sigma). At weekly intervals, tissue culture fluid (TCF) of each bottle was harvested for HAV antigen titration (EIS HAV-TEST) and replaced with fresh medium. Maxi mum release of antigen ocurred 21 days post-infectio (p.i.) in cells inoculated with HAS-15 and 28 days p.i. with HM-175. TCFs were pooled and concentrated with 10% Polyethylene glycol (Sigma) to give aproximately O.D. 1.00 (450 nm) in ELISA HAV-TEST.
The antigen was divided in aliquots of200 fil sufficient for one microplate strip to avoid repeated freezethawing and stored at -70 C.
Antiserum preparation
Convalescent serum was obtained from a pati ent with serologically confirmed hepatitis A with a anti-HAV titre of 1/200,000 in EIA (Hepanostika anti-HAV, Organon). Immunoglobulin G was purified from 10,0 ml of the serum by 2 step precipitation with ammonium sulfate, giving final concentrations 55% and 33% respectively, followed by ion-exchange chromatography on DEAE-celulose (DE-52, What man, as described by Purcell et al19. Purified IgG was stored at -20°C and used for antibody capture in a solid phase and for the preparation of enzyme linked antibody.
Anti-HA V solid ph ase preparation
Purified anti-HAV IgB with a protein concen tration of 16.8 mg/ml was diluted 1/10 in PBS (pH 7.2)/Glycerol 50% and stored in aliquots of 2,0 at -20°C until used. Activity was assayed by serial dilutions of this antibody preparation.
Conjugate Preparation
Human anti-HAV IgG (4 mg/ml) was conjuga ted to 10 mg/ml horseradish peroxidase (type VI; Sigma) by Nakane's method modified by Camargo et al^.
Checkerboard Titration
In both tests, the wells of polyvinyl microplates (Hemobag Produtos Cirurgicos Ltda) were coated with 100 //I of anti-HAV IgG diluted in 50 mM carbonate buffer pH 9.6 ( 1.51gN a2C0 3 , 3.00gNaHC03 in 1L of distilled water), covered and left overnight at 4°C. The first vertical strip was left empty in all following steps of the reaction, except at the end of the reaction, when this strip was used for substrate control and blank reading. After incubation, the wells were emptied and washed four times with phosphate buffe red saline pH 7.2 (PBS) containing 0.5% of bovine serum albumim (Sigma).
Competitive Test 1 (CO M P-1)
In this procedure, after the washing step, 50 //I of serial serum dilutions in PBS pH 7,2 were added into each well. Positive and negative sera were used as controls. Next, an aliquot of 50 jul of HAV antigen diluted in PBS pH 7.2 was dispensed into the wells.
The microplates were incubated at 37°C for 1 hour, washed four times with PBS pH 7.2 containing 0.05% of Tween 20 (PBS T). A volume of 100 jul of the human anti-HAV IgG conjugate diluted in PBS pH 7.2 with 10% of normal human serum and 10% of normal goat serum was added into each of the wells and the plates were incubated at 37°C for 1 hour. After washing four times with PBS T, 150 jul of substrate tetramethylbenzidine (TMB, Sigma) 10 mg/ml DMSO (Sigma) was added into the wells in the proportion of 6 ml phosphate-citrate buffer pH 5.0 (sodium acetate 34 g, citric acid 0,73 g in 250 ml of distilled water), 65.5 )i\ TMB and 7.2 fi\ H 2O2 30%.
After 10 minutes, the reaction was stopped by adding 50 fil of H 2SO4 2M. The plates were read photome trically at 450 nm.
Competitive Test 2 (COMP-2)
After the initial washing step, 100 jul of HAV antigen diluted in PBS pH 7.2 was dispensed into the wells and the plates were left 1 hour at 37°C for antigen adsorption. The plates were washed four times with PBS T and serum specimens (50 /il) were added into the wells, followed by 50 fil of conjugate diluted in PBS pH 7.2 with 10% normal human serum and 10% normal goat serum and incubation at 37°C for 1 hour. After washing four times with PBS T, 150 /il of TMB substrate was added and the reaction was stopped and read in the same way as describe in COMP-1.
Determination o f Cut-off Value
Cut-off levels of both procedures were calcula ted by dividing the sum of the negative control mean absorbance and the positive control mean absorbance by 2. Specimens with absorbance values greater than than the cut-off value were negative and those with absorbance values lower than or equal to the cut-off value were considered positive, corresponding to 50% of inhibition. Typical negative specimens gave an optical density between 0.60 and 0.80.
RESULTS
Three checkerboard titrations were done to determine the opimal dilutions of the reagents for each competitive test The results were expressed as N/P ratio.
Com petitive Test 1 ( COMP-1)
Figure l a shows the checkerboard titration between serum specimen and capture antibody. The capture antibody was diluted from 1/1000 to 1/32000. Positive and negative sera were tested undiluted and diluted 1/10 and 1/30. Conjugate antibody and HAV antigen were assayed without variation (1/1000 and 1/2, respectively). Three curves were obtained and the peak observed in each reveals the optimal concentra tion of the reagents tested. It can be seen that antibody capture diluted 1/8000 and sera diluted 1/10 gave better results (O.D. 0.860) although greater N/P values were found in more diluted reagents. The optimal reagent concentrations found on COMP-1 were capture antibody 1/8000, HAV anti gen 1/2, test sera 1/10 and conjugate antibody 1/1000.
Competitive Test 2 ( COMP-2)
For the competitive test 2, three checkerboard titrations were also made. Firstly, the concentrations of the components that compete on assay, sera and conjugate antibody, were tested (Table 1) . Conjugate was used in two dilutions (1/500, 1/1000) and sera were tested undiluted and diluted 1/10. Better results were obtained when more concentrated components were used (N/P 13.2). Background color, caused by free HAV-specific antigenic sites, appear if sera are used diluted 1/10 (see optical density of the positive controls).
For the checkerboard titration of capture and conjugate antibody, five and two dilutions were tested respectively as shown in Figure 2a . Positive and negative sera were assayed undiluted and HAV anti gen was diluted 1/2. Higher N values were obtained at 1/500 dilution of conjugate and 1/1000 dilution of capture antibody.
Checkerboard titration of HAV antigen and capture antibody is shown in Figure 2b . Three dilu tions of the virus were tested (1/2, 1/4, 1/8); capture antibody was diluted as described in Figure 2a . Positive and negative sera were assayed undiluted and conjugate antibody was diluted 1/500. According to N /P results, HAV antigen can be used diluted either 1/2 or 1/4, but capture antibody must be diluted 1/8000.
The optimal reagent concentrations found on COMP-2 were capture antibody 1/8000, HAV anti gen (1/4), test sera undiluted and conjugate antibody 1/500.
A reference panel (ELI SA-ORGANON) with 12 hepatitis A positive sera and 10 hepatitis A negative sera was utilized to evaluate the reproducibi lity of both competitive procedures. There was agree ment between ELISA-Organon, COMP-1 and COMP-2 in all sera tested. The results of both competitive assays are shown at 
DISCUSSION
The main factor that hampered the standardiza tion of both competitive ELISA was the growth of HAV virus and the obtention of HAV antigen in sufficient amounts that could be employed as antigen on both tests. We used two standard strains of HAV: HAS-15, which was originally isolated by the Center for Disease Control, Atlanta, GA., and HM-175, that was isolated in Australia13. Rakela et al21, had shown the morphological and serological similarities between two geographically diverse strains (Los Angeles, USA and Rosario, Argentina) and these findings supported the use of non-Brazilian strains on our study, although we have now sucessfully adapted a Brazilian isolate. Having established a culture system in FRhK-4 cells8 23, it was found that maximum release of antigen in the TCF was on day 21 for HAS-15 and on day 28 for HM-175. The culture system was optimized to yield, after approximately 20X concentration with PEG, enough antigen for 100 reactions from each 150 cm2 culture bottle. As shown by Flehming et al9, both stool-derived HAV as cell-culture produced HAV react identically in tests for anti-HAV antibodies in human sera. The use of cell-culture derived HAV es diagnostic reagent free of the inherent problems associated with reagents of human or primate origin4.
The object of the present study was to standar dise and compare two EIA competitive methods for the detection of anti-HAV antibodies, with the aim of developing an assay giving clear cut results and being easy to perform and economic in reagents.
Four components of both procedures (COMP-1, COMP-2) were analysed: capture and conjugate antibody, serum specimens and HAV antigen. The choice of an optimal dilution of reagents in each checkerboard titration made possible both N/P value and visual discrimination between positive and nega tive samples. Positive samples must give O.D. (450 nm) smaller than 0.100 and negative ones higher than 0.700. Given the high costs in producing conjugates and the difficulty in obtaining HAV antigen, the quantity needed of these reagents was also an impor tant consideratioa Like Parry16, we also found that the most critical procedure to improve sensitivity was to deter mine the coating antibody dilution that gives the greatest discrimination between negative and positive samples (N/P). In all checkerboard tests made for both assays, it was seen that dilution of capture antibody increase N /P ratios whatever the component being tested A 2-to 4-fold deviation of the optimal dilution may result in 55.5% loss of sensitibity on COMP-1 and 46,15% on COMP-2. In COMP-1, the competi tion occurs between capture and serum specimen antibodies by the HAV antigen epitopes; hence, sera dilution will depend upon the dilution of the capture antibody used.
In competitive assays, it is important to limit the amount of antigen to provide the greatest sensitivity. Studies have shown that too much antigen requires a lot of antibody activity in the specimen to adequately block the antigenic sites. Concerning HAV antigen, better results were achieved using lower dilutions, which showed no prozone effect16. However, as its production is a critical factor, the dilution used on both procedures was the minimum that acceptable N/P ratio. We also observed that repeated freeze-thawing of the HAV antigen can greatly reduce its titre and consequently, the sensitivity of the test Is was obser ved when we evaluated both procedures using a reference panel. It is recomended that HAV antigen be stored in small aliquots and always thawed in an ice bath.
In COMP-2, as the competition occurs between serum specimen and conjugate antibodies, sera cannot be diluted, otherwise free sites on HAV antigen will permit binding of conjugate antibodies producing background color in positive samples and consequen tly, false positive results.
Satisfactory results were achieved using more diluted conjugate antibody (1/1000) in COMP-1 in spite of greater N/P value obtained at dilution 1/500.
In this case, is preferable to choose a dilution with lower N/P value but with no background color on positive sera samples to prevent false nagative results. The color of negative samples in COMP-2 test is proportional to the amount of conjugate antibody reacted. Hence, the relation between serum specimen and conjugate antibodies must be one that gives no color with positive sera, and higher O.D. with negative sera.
Horseradish peroxidase can be detected with a variety of substrates which usually become oxidized to an insoluble polymer when the peroxidase catalyses the release of oxygen from hydrogen peroxide. We chose TMB as substrate after tests with o-phenylenediamine (OPD). Basides being safer, TMB was shown to be more sensitive, as also observed by Bos et al1.
The time spent in the performance of the test was also considered important in Hepatitis A diagno sis. After an overnight incubation with capture antibo dy, we reduced to approximately 3 hours the period of both procedures, which is shorter than those of other competitive immunossays3 22 We conclude that both competitive tests are suitable for diagnostic routine, with high sensitivity and specificity. Moreover, they can be easily repro duced and applied in any diagnostic laboratory besides being useful as an important tool in Hepatitis A research. 
RESUMO
